Ever since Ozempic became more profitable to sell to fat people looking for an easy weight loss hack rather than the diabetics who actually needed it, we've seen nothing but bullshit attributed to the drug.
this post was submitted on 02 Apr 2024
71 points (91.8% liked)
Piracy: ꜱᴀɪʟ ᴛʜᴇ ʜɪɢʜ ꜱᴇᴀꜱ
55072 readers
568 users here now
⚓ Dedicated to the discussion of digital piracy, including ethical problems and legal advancements.
Rules • Full Version
1. Posts must be related to the discussion of digital piracy
2. Don't request invites, trade, sell, or self-promote
3. Don't request or link to specific pirated titles, including DMs
4. Don't submit low-quality posts, be entitled, or harass others
Loot, Pillage, & Plunder
📜 c/Piracy Wiki (Community Edition):
💰 Please help cover server costs.
 |
 |
|---|---|
| Ko-fi | Liberapay |
founded 2 years ago
MODERATORS
Some medicine shouldn't be allowed to have copyright.
No medicines have copyrights, but they do have patents. And, drug patents are kinda necessary if you want money to be spent on developing new drugs.
No one is going to dump a few hundred million into developing a new drug if everyone can manufacture and sell it upon release.
Patents aren't the issue, though, it's companies charging out the ass because they can.
Publicly funded research is out of the question then? Why does it have to be private corporations doing the research?
Oh, the patent expired? No problem, we'll just methylate the structure, see that it makes no difference and put it out on the market as a new drug. Or maybe take the active part of a racemic mixture and half the dosage. Same drug double the patent. Semisynthetic insulin is even worse in that regard.
No one is going to dump a few hundred million into developing a new drug if everyone can manufacture and sell it upon release.
You won't sell it on the market because you have to produce it cheaper or at the same cost as the competition. You don't have the knowledge to produce the drug efficiently, and you can't learn that by looking at the end product. In a society without IP, the most important things are the optimised production processes, which will be kept secret. The rest can be copied because it will be more expensive to produce.
*All
All would come with the problem that the companys stop investing into research. This would be compensatable by government funded research, but it would be a very large restructuring.
I think its ok for them to hold patents for some medicine, as long as they sell it for a reasonable price. Those patents however should expire after like 5 years.
Why do you think that medication patents are a bad thing?
I read the article and I don't think it factors in the upfront cost of R&D, Compliance, etc, so that's basically a fantasy number.
You're probably right. It's more than likely the cost per dose. Which is also what the $1000 figure represents.
The Vermont independent (Bernie) called on Novo Nordisk to lower the list price of Ozempic to $155 a month or less, in line with what it charges in other countries.
Somehow they can justify selling it for $155 a dose (per month?) in other countries while still making a profit above the overhead and compliance costs.
Those are the costs of doing business, and can be greatly exaggerated. And other counties produce profitable drugs even with price restrictions. We're so accustomed to price gouging, that we don't recognize it.